Pasithea Therapeutics announced a virtual key opinion leader event on November 4, 2026, to discuss unmet needs and treatment options for neurofibromatosis type 1 (NF1), focusing on cutaneous and plexiform neurofibromas. The event will feature experts Dr. Rebecca M. Brown and Dr. Kavita Sarin alongside company management, highlighting the potential of Pasithea's PAS-004, a next-generation oral MEK inhibitor currently in Phase 1 trials. The company will review recent clinical data and explore the commercial opportunity for PAS-004 in treating NF1-related tumors. This event underscores Pasithea's efforts to advance treatments for rare diseases driven by the MAPK pathway.
Pasithea Therapeutics' upcoming virtual event on NF1 treatment provides context for health sector activity. As of Oct 29, 2026 03:21 WIB, 103 of 150 priced health-sector US stocks on Pluang rose while 46 fell. Notable movers include Inovio Pharmaceuticals Inc (INO) at USD 0.95 with a 6.22% increase and a typical hold time of 43 days, and Recursion Pharmaceuticals Inc (RXRX) at USD 4.30, up 6.17%, with 84% sell order activity.
SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...
SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...
SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...
The global dermatological therapeutics market is projected to grow from about $43 billion in 2025 to $97 billion by 2034, with a compound annual growth rate of around 10%. This growth is fueled by increasing cases of acne, psoriasis, and other chroni...
Blockchain.com has launched TRX options trading, providing easier access to TRON's native token through its platform. This move expands the TRON ecosystem's reach by simplifying options trading for retail and institutional users worldwide. TRON, know...
